Is PhaseBio Pharmaceuticals (PHAS) A Good Stock To Buy Now?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Phasebio Pharmaceuticals Inc (PHAS)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | DAFNA Capital Management Nathan Fischel | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.08 | 3,000 | $9,240.00 | 4,000 | 2021-08-18 | Filing | |
| $3.08 | 3,000 | $9,240.00 | 4,000 | 2021-08-18 | Filing | |
| $3.00 | 10,000 | $30,000.00 | 32,943 | 2021-08-18 | Filing | |
| $4.12 | 6,000 | $24,720.00 | 6,000 | 2020-12-03 | Filing | |
| $3.50 | 2,000 | $7,000.00 | 22,943 | 2020-11-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.15 | 1,784,109 | $262,264.02 | 4,857,525 | 2022-10-25 | Filing | |
| $0.79 | 11,248 | $8,885.92 | 0 | 2022-05-23 | Filing | |
| $2.37 | 5,766 | $13,665.42 | 0 | 2021-11-19 | Filing | |
| $3.29 | 3,811 | $12,538.19 | 0 | 2021-05-20 | Filing | |
| $3.45 | 3,497 | $12,064.65 | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Hedge Funds Are Selling PhaseBio Pharmaceuticals, Inc. (PHAS)
In this article we will take a look at whether hedge funds think PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) is a good investment right now.
Hedge Funds Have Never Been This Bullish On PhaseBio Pharmaceuticals, Inc. (PHAS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On PhaseBio Pharmaceuticals, Inc. (PHAS)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Hedge Fund Resource Center Billionaire Hedge Funds
